Description:

This course will examine new findings pertaining to the diagnosis and management of central serious chorioretinopathy (CSCR) and what they mean for the practicing optometrist.  Key findings from recent studies will be discussed in order to provide an update on the etiology, manifestations, and pathophysiology of this condition.  We will also discuss the role of newer technologies such as enhanced depth imaging and OCT angiography on diagnosis.  Lastly, novel treatment options, including mineralocorticoid antagonist medications and subthreshold micropulse laser, will be assessed and incorporated into a current evidence-based management plan for various presentations of CSCR.

Course Code:

AOA115-PS

Speaker(s):

James Rogala, O.D.
jamesrogala@upike.edu

Credits:

1

AOA Expiration Date:

3/30/2024

Related News

California warily watches ‘not-a-doctor’ wording in Senate bill

A recently amended California bill tackles who can and can’t be called a doctor in California. The California Optometric Association is on top of the issue, making sure the exclusionary wording does not apply to the state’s doctors of optometry. Not-a-doctor legislation emerged in several states last year, each effort defeated by optometry.

Contacts Lens Prescription Modernization Act introduced as next step in ending damaging robocalls

The fight to end the problematic loophole of robocalls continues with the introduction of Senate bill S.4083, a companion bill to H.R. 2748 from 2023.

'All the advocacy firepower’ called up at AOA on Capitol Hill

Over 500 AOA doctors and optometry students championed the profession’s priority issues in Washington, D.C., including a growing Congressional focus on vision plan abuses.